Impact of Hypomethylating Agents on AML Treatment With HAG Priming
The following is a summary of “Effect of hypomethylating agents on prognosis in acute myeloid leukemia patients treated with HAG priming: a systematic review and meta-analysis,” published in the December 2024 issue of Hematology by Li et al. Hypomethylation agents...
Patient Initiated Follow up in SpA With Asynchronous TM
The following is a summary of “Experiences with patient-initiated follow-up supported by asynchronous telemedicine in spondyloarthritis: a mixed methods study,” published in the December 2024 issue of Rheumatology by Smits et al. Researchers conducted a retrospective...
BP Effects of LD-MTX in Patients With CVD
The following is a summary of “Blood Pressure Changes During Methotrexate Treatment: Results from a Randomized Placebo-Controlled Trial Among Patients with Cardiovascular Risk,” published in the December 2024 issue of Rheumatology by Cui et al. Low dose methotrexate...
Patient Reported Outcomes Reflecting Disease Status in axSpA
The following is a summary of “Association of validated patient reported outcome measures with patients’ self-reported disease status in axial spondyloarthritis,” published in the December 2024 issue of Rheumatology by Redeker et al. Validated PROs in axial...
Role of CTI as a Predictor of Depressive Symptoms
The following is a summary of “Association between C-reactive protein-triglyceride glucose index and depressive symptoms in American adults: results from the NHANES 2005 to 2010,” published in the December 2024 issue of Psychiatry by Huang et al. C-reactive...
Molecular Requirements for IL-9 Expression in Human CD4+ T Cells
The following is a summary of “Inborn errors of immunity reveal the molecular requirements for the generation and maintenance of human IL-9 expressing cells.,” published in the November 2024 issue of Allergy and Immunology by Rao et al. CD4+ T cells are crucial in...
Transformation of Clinic Services and Community Support Post COVID-19
The following is a summary of “Evolution of Medical and Community Resource Services Within a Student-Run Clinic Following COVID-19 Pandemic,” published in the December 2024 issue of Primary Care by Zaremba et al. The COVID-19 pandemic led to resource redistribution,...
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has issued its most serious warning -- a black-box warning -- for Veozah, a medication used to relieve hot flashes in menopausal women, due to rare but potentially severe liver...
AI Performs Well in Identifying Infantile Epileptic Spasms
WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- Deep learning analysis can be used to detect epileptic spasms (ES) from smartphone home videos of young children, according to a study presented at the annual meeting of the American Epilepsy Society, held from Dec. 6 to 10...
Neurocognitive Battery Feasible in 3-Year-Olds During Leukemia Treatment
WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a study published online Dec. 9 in Pediatric Blood & Cancer.Sameera Ramjan, from Memorial...
Impact of Hypomethylating Agents on AML Treatment With HAG Priming
The following is a summary of “Effect of hypomethylating agents on prognosis in acute myeloid leukemia patients treated with HAG priming: a systematic review and meta-analysis,” published in the December 2024 issue of Hematology by Li et al. Hypomethylation agents...
Patient Initiated Follow up in SpA With Asynchronous TM
The following is a summary of “Experiences with patient-initiated follow-up supported by asynchronous telemedicine in spondyloarthritis: a mixed methods study,” published in the December 2024 issue of Rheumatology by Smits et al. Researchers conducted a retrospective...
BP Effects of LD-MTX in Patients With CVD
The following is a summary of “Blood Pressure Changes During Methotrexate Treatment: Results from a Randomized Placebo-Controlled Trial Among Patients with Cardiovascular Risk,” published in the December 2024 issue of Rheumatology by Cui et al. Low dose methotrexate...
Patient Reported Outcomes Reflecting Disease Status in axSpA
The following is a summary of “Association of validated patient reported outcome measures with patients’ self-reported disease status in axial spondyloarthritis,” published in the December 2024 issue of Rheumatology by Redeker et al. Validated PROs in axial...
Role of CTI as a Predictor of Depressive Symptoms
The following is a summary of “Association between C-reactive protein-triglyceride glucose index and depressive symptoms in American adults: results from the NHANES 2005 to 2010,” published in the December 2024 issue of Psychiatry by Huang et al. C-reactive...
Molecular Requirements for IL-9 Expression in Human CD4+ T Cells
The following is a summary of “Inborn errors of immunity reveal the molecular requirements for the generation and maintenance of human IL-9 expressing cells.,” published in the November 2024 issue of Allergy and Immunology by Rao et al. CD4+ T cells are crucial in...
Transformation of Clinic Services and Community Support Post COVID-19
The following is a summary of “Evolution of Medical and Community Resource Services Within a Student-Run Clinic Following COVID-19 Pandemic,” published in the December 2024 issue of Primary Care by Zaremba et al. The COVID-19 pandemic led to resource redistribution,...
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has issued its most serious warning -- a black-box warning -- for Veozah, a medication used to relieve hot flashes in menopausal women, due to rare but potentially severe liver...
AI Performs Well in Identifying Infantile Epileptic Spasms
WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- Deep learning analysis can be used to detect epileptic spasms (ES) from smartphone home videos of young children, according to a study presented at the annual meeting of the American Epilepsy Society, held from Dec. 6 to 10...
Neurocognitive Battery Feasible in 3-Year-Olds During Leukemia Treatment
WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a study published online Dec. 9 in Pediatric Blood & Cancer.Sameera Ramjan, from Memorial...
